. . . . . . . . . . . . "[So far, a beneficial effect of combined angiotensin-converting enzyme inhibitors (ACEI) and -blocker therapy for systolic dysfunction in Duchenne muscular dystrophy (DMD) has been reported only in patients in whom DMD was due to deletions in the dystrophin gene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2013-07-24"^^ . . "Gene-disease associations manually curated."@en . "DisGeNET evidence - CURATED"@en . "2014-10-02T12:32:04+02:00"^^ . . . . . . . . . . . "v2.1.0.0" . "v2.1.0" .